These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8373765)

  • 1. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine.
    Gilbert GE; Drinkwater D
    Biochemistry; 1993 Sep; 32(37):9577-85. PubMed ID: 8373765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.
    Shi J; Heegaard CW; Rasmussen JT; Gilbert GE
    Biochim Biophys Acta; 2004 Nov; 1667(1):82-90. PubMed ID: 15533308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylethanolamine induces high affinity binding sites for factor VIII on membranes containing phosphatidyl-L-serine.
    Gilbert GE; Arena AA
    J Biol Chem; 1995 Aug; 270(31):18500-5. PubMed ID: 7629178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres).
    Gilbert GE; Drinkwater D; Barter S; Clouse SB
    J Biol Chem; 1992 Aug; 267(22):15861-8. PubMed ID: 1639816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy.
    Gilbert GE; Baleja JD
    Biochemistry; 1995 Mar; 34(9):3022-31. PubMed ID: 7893714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived microparticles express high affinity receptors for factor VIII.
    Gilbert GE; Sims PJ; Wiedmer T; Furie B; Furie BC; Shattil SJ
    J Biol Chem; 1991 Sep; 266(26):17261-8. PubMed ID: 1654328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.
    Purohit VS; Ramani K; Sarkar R; Kazazian HH; Balasubramanian SV
    J Biol Chem; 2005 May; 280(18):17593-600. PubMed ID: 15728582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-binding properties of the Factor VIII C2 domain.
    Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE
    Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.
    Gilbert GE; Novakovic VA; Shi J; Rasmussen J; Pipe SW
    Blood; 2015 Sep; 126(10):1237-44. PubMed ID: 26162408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII organisation on nanodiscs with different lipid composition.
    Grushin K; Miller J; Dalm D; Stoilova-McPhie S
    Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity.
    Gilbert GE; Novakovic VA; Kaufman RJ; Miao H; Pipe SW
    Blood; 2012 Aug; 120(9):1923-32. PubMed ID: 22613792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid structure and not membrane structure is the major determinant in the regulation of protein kinase C by phosphatidylserine.
    Johnson JE; Zimmerman ML; Daleke DL; Newton AC
    Biochemistry; 1998 Sep; 37(35):12020-5. PubMed ID: 9724512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of recombinant human coagulation factor VIII to lipid nanotubes.
    Parmenter CD; Stoilova-McPhie S
    FEBS Lett; 2008 May; 582(12):1657-60. PubMed ID: 18435924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of factor VIII with phospholipids: role of composition and negative charge.
    Kemball-Cook G; Barrowcliffe TW
    Thromb Res; 1992 Jul; 67(1):57-71. PubMed ID: 1440515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Blood; 1990 May; 75(10):1999-2004. PubMed ID: 2110840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of human factor VIII to phospholipid vesicles.
    Gilbert GE; Furie BC; Furie B
    J Biol Chem; 1990 Jan; 265(2):815-22. PubMed ID: 2104832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidyl-L-serine is necessary for protein kinase C's high-affinity interaction with diacylglycerol-containing membranes.
    Newton AC; Keranen LM
    Biochemistry; 1994 May; 33(21):6651-8. PubMed ID: 8204602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and phospholipid binding property of the C2 domain of human factor VIII.
    Takeshima K; Smith C; Tait J; Fujikawa K
    Thromb Haemost; 2003 May; 89(5):788-94. PubMed ID: 12719774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity.
    Meems H; Meijer AB; Cullinan DB; Mertens K; Gilbert GE
    Blood; 2009 Oct; 114(18):3938-46. PubMed ID: 19687511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.